{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:05:05Z","timestamp":1791227105956,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jcf.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T00:08:54Z","timestamp":1454717334000},"page":"340-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Microbial colonization and lung function in adolescents with cystic fibrosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Andreas","family":"Hector","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Ralhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Graepler-Mainka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Berenbrinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Riethmueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pfleger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Autenrieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Griese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Eber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2016.01.004_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4187\/aarc0427","article-title":"Cystic fibrosis: pathogenesis and future treatment strategies","volume":"54","author":"Ratjen","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2016.01.004_bb0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201407-1277OC","article-title":"Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis","volume":"190","author":"Ramsey","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201404-0681OC","article-title":"Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes","volume":"190","author":"Mayer-Hamblett","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"Doring","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2008.08.001","article-title":"Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis","volume":"154","author":"Sagel","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2016.01.004_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-0029-1238917","article-title":"The approach to Pseudomonas aeruginosa in cystic fibrosis","volume":"30","author":"Bendiak","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1513\/AnnalsATS.201402-050AS","article-title":"Antibiotic management of lung infections in cystic fibrosis. I. the microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections","volume":"11","author":"Chmiel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2016.01.004_bb0050","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1513\/AnnalsATS.201405-203AS","article-title":"Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi","volume":"11","author":"Chmiel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2016.01.004_bb0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2174\/138161212799315939","article-title":"New treatments for emerging cystic fibrosis pathogens other than Pseudomonas","volume":"18","author":"Waters","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcf.2016.01.004_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prrv.2010.07.003","article-title":"Challenging and emerging pathogens in cystic fibrosis","volume":"11","author":"de Vrankrijker","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2016.01.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.201412-596OC","article-title":"Multicenter observational study on factors and outcomes associated with different MRSA types in children with cystic fibrosis","author":"Muhlebach","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2016.01.004_bb0070","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","volume":"2","author":"Lo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2016.01.004_bb0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/cid\/cit270","article-title":"Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis","volume":"57","author":"Wolter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2016.01.004_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2011.06.002","article-title":"Review: Staphylococcus aureus and MRSA in cystic fibrosis","volume":"10","author":"Goss","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MCP.0b013e32834b95ed","article-title":"Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis","volume":"17","author":"Dasenbrook","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0090","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2016.01.004_bb0095","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.201405-0884OC","article-title":"Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk","volume":"190","author":"Adjemian","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MCP.0b013e328365ab33","article-title":"Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis","volume":"19","author":"Leung","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-2004-815665","article-title":"Nontuberculous mycobacteria in cystic fibrosis","volume":"24","author":"Nick","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.2301001","article-title":"Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis","volume":"167","author":"Griffith","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thx.2003.017707","article-title":"Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis","volume":"59","author":"Goss","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2016.01.004_bb0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1164\/rccm.201009-1392OC","article-title":"Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease","volume":"183","author":"Waters","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcf.2011.07.008","article-title":"Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis","volume":"11","author":"Waters","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2012.12.006","article-title":"Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients","volume":"12","author":"Waters","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jcf.2013.05.009","article-title":"Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients","volume":"12","author":"Stanojevic","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0150","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(14)61137-5","article-title":"Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis","volume":"384","author":"Sherrard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2016.01.004_bb0155","unstructured":"Atemwegsinfecktionen bei Mukoviszidose. Mikrobiologisch-infektiologische Qualit\u00e4tsstandards MiQ Qualit\u00e4tssicherungskommission der Deutschen Gesellschaft f\u00fcr Hygiene und Mikrobiologie (DGHM). 2006;24."},{"key":"10.1016\/j.jcf.2016.01.004_bb0160","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01182-09","article-title":"EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates","volume":"47","author":"Hogardt","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2007.02.007","article-title":"A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis","volume":"7","author":"Balke","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0170","doi-asserted-by":"crossref","unstructured":"Standardization of Spirometry \u2014 1994 Update. Am J Respir Crit Care Med. (1995);152:1107\u20131136.","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"10.1016\/j.jcf.2016.01.004_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2016.01.004_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.004_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.jcf.2016.01.004_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0195","series-title":"Annual Data Report to the Center Directors, Bethesda, MD","author":"Registry","year":"2013"},{"key":"10.1016\/j.jcf.2016.01.004_bb0200","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/ppul.22863","article-title":"Hart E, Australian respiratory early surveillance team for cystic F. Staphylococcus aureus in early cystic fibrosis lung disease","volume":"48","author":"Wong","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0205","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.3109\/13693786.2010.503320","article-title":"Candida Species in cystic fibrosis: a road less travelled","volume":"48","author":"Chotirmall","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0210","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.09-2996","article-title":"Sputum Candida albicans presages FEV(1) decline and hospital-treated exacerbations in cystic fibrosis","volume":"138","author":"Chotirmall","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2016.01.004_bb0215","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/cmi.12091","article-title":"Two unlike cousins: Candida albicans and C. glabrata infection strategies","volume":"15","author":"Brunke","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0220","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/rccm.201203-0478OC","article-title":"The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis","volume":"186","author":"Coughlan","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2016.01.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2016.01.004_bb0235","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ejrad.2011.01.114","article-title":"Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population","volume":"81","author":"McMahon","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0240","article-title":"What is the importance of classifying Aspergillus disease in cystic fibrosis patients?","volume":"1-4","author":"Jones","year":"2014","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2014.03.001","article-title":"Fungi in the cystic fibrosis lung: bystanders or pathogens?","volume":"52","author":"Chotirmall","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2016.01.004_bb0255","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/thoraxjnl-2012-202412","article-title":"Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum","volume":"68","author":"Baxter","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2016.01.004_bb0260","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MCP.0b013e32833e24a6","article-title":"Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis","volume":"16","author":"Moss","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2016.01.004_bb0265","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","article-title":"The cystic fibrosis lung microbiome","volume":"11","author":"Surette","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2016.01.004_bb0270","doi-asserted-by":"crossref","first-page":"a009738","DOI":"10.1101\/cshperspect.a009738","article-title":"The cystic fibrosis airway microbiome","volume":"3","author":"Lynch","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcf.2016.01.004_bb0275","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.06.00100805","article-title":"Evaluating the \u201cLeeds criteria\u201d for Pseudomonas aeruginosa infection in a cystic fibrosis centre","volume":"27","author":"Proesmans","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2016.01.004_bb0280","doi-asserted-by":"crossref","unstructured":"Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, et al. Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. J Cyst Fibros. 2015.","DOI":"10.1016\/j.jcf.2015.09.007"},{"key":"10.1016\/j.jcf.2016.01.004_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2014.08.002","article-title":"Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia","volume":"14","author":"Qvist","year":"2015","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:21:06Z","timestamp":1718346066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199316000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1569199316000114"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2016.01.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial colonization and lung function in adolescents with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}